ABAXIS Company Profile (NASDAQ:ABAX)

About ABAXIS (NASDAQ:ABAX)

Abaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:

Sector: Medical
Industry: Advanced Medical Equipment & Technology
Sub-Industry: Health Care Equipment
Symbol: NASDAQ:ABAX
CUSIP: 00256710
Web: www.abaxis.com

Capitalization:

Market Cap: $1.01745 billion
Outstanding Shares: 22,690,000

Average Prices:

50 Day Moving Avg: $45.94
200 Day Moving Avg: $48.63
52 Week Range: $43.66 - $55.95

P/E:

Trailing P/E Ratio: 31.67
Foreward P/E Ratio: 34.49
P/E Growth: 7.46

Sales & Book Value:

Annual Revenue: $227.78 million
Price / Sales: 4.47
Book Value: $11.97 per share
Price / Book: 3.75

Dividend:

Annual Dividend: $0.56
Dividend Yield: 1.3%

Profitability:

EBIDTA: $49.81 million
Net Margins: 14.12%
Return on Equity: 10.85%
Return on Assets: 9.44%

Debt:

Current Ratio: 5.67%
Quick Ratio: 4.65%

Misc:

Average Volume: 110,314 shs.
Beta: 0.81
Short Ratio: 18.88

Frequently Asked Questions for ABAXIS (NASDAQ:ABAX)

What is ABAXIS's stock symbol?

ABAXIS trades on the NASDAQ under the ticker symbol "ABAX."

How often does ABAXIS pay dividends? What is the dividend yield for ABAXIS?

ABAXIS declared a quarterly dividend on Thursday, July 27th. Investors of record on Friday, September 1st will be given a dividend of $0.14 per share on Friday, September 15th. This represents a $0.56 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Wednesday, August 30th. View ABAXIS's Dividend History.

How were ABAXIS's earnings last quarter?

ABAXIS, Inc. (NASDAQ:ABAX) released its quarterly earnings results on Thursday, July, 27th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.33 by $0.05. The company earned $58.26 million during the quarter, compared to analysts' expectations of $60.37 million. ABAXIS had a net margin of 14.12% and a return on equity of 10.85%. The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.30 EPS. View ABAXIS's Earnings History.

When will ABAXIS make its next earnings announcement?

ABAXIS is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for ABAXIS.

Where is ABAXIS's stock going? Where will ABAXIS's stock price be in 2017?

6 brokerages have issued 1 year target prices for ABAXIS's stock. Their predictions range from $42.00 to $56.50. On average, they expect ABAXIS's stock price to reach $48.63 in the next year. View Analyst Ratings for ABAXIS.

Who are some of ABAXIS's key competitors?

Some companies that are related to ABAXIS include Quidel Corporation (QDEL), Accelerate Diagnostics (AXDX), Mazor Robotics (MZOR), Natus Medical Incorporated (BABY), Luminex Corporation (LMNX), LeMaitre Vascular (LMAT), Pacific Biosciences of California (PACB), GenMark Diagnostics (GNMK), Accuray Incorporated (ARAY), ViewRay (VRAY), Corindus Vascular Robotics (CVRS), Cogentix Medical (CGNT), Cytosorbents Corporation (CTSO), Neovasc (NVCN), Harvard Bioscience (HBIO), Viveve Medical (VIVE), IRIDEX Corporation (IRIX) and EDAP TMS S.A. (EDAP).

Who are ABAXIS's key executives?

ABAXIS's management team includes the folowing people:

Clinton H. Severson, Chairman of the Board, Chief Executive Officer
Donald Peter Wood, President, Chief Operating Officer
Ross Taylor, Chief Financial Officer, Vice President - Finance, Secretary
Kenneth P. Aron Ph.D., Chief Technology Officer
Craig M. Tockman, Vice President - Animal Health Sales and Marketing for North America
Achim Henkel, Managing Director of Abaxis Europe GmbH
Vernon Edward Altman, Lead Independent Director
Richard J. Bastiani Ph.D., Independent Director
Michael D. Casey, Independent Director
Henk J. Evenhuis, Independent Director

Who owns ABAXIS stock?

ABAXIS's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Kayne Anderson Rudnick Investment Management LLC (13.85%), BlackRock Inc. (11.76%), Vanguard Group Inc. (8.68%), Neuberger Berman Group LLC (3.34%), Dimensional Fund Advisors LP (2.97%) and Wells Fargo & Company MN (2.78%). Company insiders that own ABAXIS stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Prithipal Singh, Richard Bastiani and Vernon E Altman. View Institutional Ownership Trends for ABAXIS.

Who sold ABAXIS stock? Who is selling ABAXIS stock?

ABAXIS's stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Ameriprise Financial Inc., Tiverton Asset Management LLC, BlackRock Inc., Neuberger Berman Group LLC, Goldman Sachs Group Inc., Bank of New York Mellon Corp and PDT Partners LLC. Company insiders that have sold ABAXIS stock in the last year include Achim Henkel, Clinton Severson, Kenneth Aron and Richard Bastiani. View Insider Buying and Selling for ABAXIS.

Who bought ABAXIS stock? Who is buying ABAXIS stock?

ABAXIS's stock was bought by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Copeland Capital Management LLC, Eaton Vance Management, AMI Asset Management Corp, Russell Investments Group Ltd., Vanguard Group Inc., Spark Investment Management LLC and Dimensional Fund Advisors LP. View Insider Buying and Selling for ABAXIS.

How do I buy ABAXIS stock?

Shares of ABAXIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ABAXIS's stock price today?

One share of ABAXIS stock can currently be purchased for approximately $44.84.

MarketBeat Community Rating for ABAXIS (NASDAQ ABAX)

Community Ranking:		1.6 out of 5 ()
Outperform Votes:		108 (Vote Outperform)
Underperform Votes:		232 (Vote Underperform)
Total Votes:		340

MarketBeat's community ratings are surveys of what our community members think about ABAXIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for ABAXIS (NASDAQ:ABAX) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:	Hold (Score: 2.00)
Consensus Price Target:	$48.63 (8.44% upside)

Analysts' Ratings History for ABAXIS (NASDAQ:ABAX)

Show:

Date	Firm	Action	Rating	Price Target	Impact on Share Price
8/23/2017	Bank of America Corporation	Reiterated Rating	Underperform -> Underperform	$42.00	High
7/14/2017	Stifel Nicolaus	Reiterated Rating	Hold	$48.00	Low
6/9/2017	Aegis	Initiated Coverage	Hold	$56.50	High
2/14/2017	Canaccord Genuity	Reiterated Rating	Hold	$48.00	N/A
2/1/2017	Seaport Global Securities	Upgrade	Buy		N/A
11/30/2016	Northcoast Research	Downgrade	Buy -> Neutral		N/A
8/16/2016	Credit Suisse Group	Reiterated Rating	Sell	$39.00	N/A
7/22/2016	Feltl & Co.	Downgrade	Hold -> Sell		N/A
4/1/2016	CL King	Initiated Coverage	Neutral		N/A
1/29/2016	Piper Jaffray Companies	Lower Price Target	Neutral	$49.00 -> $45.00	N/A

(Data available from 9/25/2015 forward)

Earnings History for ABAXIS (NASDAQ:ABAX)

Earnings by Quarter for ABAXIS (NASDAQ:ABAX)

Earnings History by Quarter for ABAXIS (NASDAQ ABAX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/23/2017		$0.30					N/A
7/27/2017	Q1 2018	$0.33	$0.28	$60.37 million	$58.26 million	View	N/A
4/27/2017	Q4 2017	$0.33	$0.33	$58.04 million	$58.20 million	View	N/A
1/26/2017	Q317	$0.31	$0.30	$54.36 million	$52.80 million	View	N/A
10/25/2016	Q217	$0.35	$0.34	$60.69 million	$58.60 million	View	Listen
7/21/2016	Q117	$0.32	$0.30	$58.70 million	$57.70 million	View	Listen
4/28/2016	Q416	$0.32	$0.36	$56.62 million	$57.00 million	View	Listen
1/28/2016	Q316	$0.33	$0.35	$58.52 million	$52.90 million	View	Listen
10/27/2015	Q216	$0.32	$0.34	$56.20 million	$56.00 million	View	Listen
7/23/2015	Q116	$0.28	$0.31	$53.75 million	$53.10 million	View	Listen
4/30/2015	Q415	$0.27	$0.17	$55.62 million	$52.00 million	View	N/A
1/29/2015	Q315	$0.25	$0.26	$51.70 million	$59.50 million	View	N/A
10/21/2014	Q215	$0.23	$0.24	$50.55 million	$53.90 million	View	Listen
7/24/2014	Q115	$0.19	$0.21	$46.95 million	$47.50 million	View	N/A
4/24/2014	Q414	$0.19	$0.17	$45.74 million	$42.04 million	View	N/A
1/31/2014	Q314	$0.20	$0.14	$49.47 million	$40.00 million	View	N/A
10/22/2013	Q114	$0.21	$0.18	$48.60 million	$45.90 million	View	N/A
7/25/2013	Q1 2014	$0.23	$0.14	$49.13 million	$43.20 million	View	Listen
4/25/2013	Q4 2013	$0.26	$0.30	$52.47 million	$50.00 million	View	Listen
1/31/2013	Q3 2013	$0.20	$0.22	$45.75 million	$49.80 million	View	Listen
10/23/2012		$0.18	$0.18			View	N/A
7/26/2012		$0.17	$0.13			View	N/A
4/26/2012		$0.16	$0.21			View	N/A
1/26/2012		$0.16	$0.13			View	N/A
10/25/2011		$0.14	$0.15			View	N/A
7/28/2011		$0.16	$0.10			View	N/A
4/28/2011		$0.16	$0.15			View	N/A
1/27/2011		$0.18	$0.17			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for ABAXIS (NASDAQ:ABAX)

2017 EPS Consensus Estimate: $1.29
2018 EPS Consensus Estimate: $1.39

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2017	1	$0.34	$0.34	$0.34
Q2 2017	1	$0.34	$0.34	$0.34
Q3 2017	2	$0.29	$0.32	$0.31
Q4 2017	2	$0.27	$0.33	$0.30
Q1 2018	1	$0.33	$0.33	$0.33
Q2 2018	1	$0.38	$0.38	$0.38
Q3 2018	1	$0.31	$0.31	$0.31
Q4 2018	1	$0.37	$0.37	$0.37

(Data provided by Zacks Investment Research)

Current Dividend Information for ABAXIS (NASDAQ:ABAX)

Most Recent Dividend:	9/15/2017
Annual Dividend:	$0.56
Dividend Yield:	1.25%
Payout Ratio:	39.72% (Trailing 12 Months of Earnings) 49.12% (Based on This Year's Estimates) 43.08% (Based on Next Year's Estimates)

Dividend Payments by Quarter for ABAXIS (NASDAQ:ABAX)

Dividend History by Quarter for ABAXIS (NASDAQ ABAX)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/27/2017	quarterly	$0.14	1.19%	8/30/2017	9/1/2017	9/15/2017
4/27/2017	quarterly	$0.14	1.24%	5/30/2017	6/1/2017	6/15/2017
1/26/2017	quarterly	$0.14	1.13%	2/27/2017	3/1/2017	3/15/2017
10/28/2016	quarterly	$0.14	1.17%	11/29/2016	12/1/2016	12/15/2016
7/21/2016	quarterly	$0.12	1.04%	8/30/2016	9/1/2016	9/15/2016
4/28/2016	quarterly	$0.12	1.06%	6/1/2016	6/3/2016	6/17/2016
1/28/2016	quarterly	$0.11	1.01%	3/1/2016	3/3/2016	3/17/2016
11/3/2015	quarterly	$0.11	0.84%	12/1/2015	12/3/2015	12/17/2015
7/23/2015	quarterly	$0.11	0.9%	9/1/2015	9/3/2015	9/17/2015
4/30/2015	quarterly	$0.11	0.79%	6/2/2015	6/4/2015	6/18/2015
1/30/2015	quarterly	$0.10	0.65%	2/27/2015	3/3/2015	3/17/2015
10/23/2014	quarterly	$0.10	0.82%	11/13/2014	11/17/2014	12/16/2014
7/24/2014	quarterly	$0.10	0.86%	8/29/2014	9/3/2014	9/17/2014
4/24/2014	quarterly	$0.10		5/30/2014	6/3/2014	6/17/2014
12/6/2012	special	$1.00		12/13/2012	12/17/2012	12/28/2012

(Data available from 1/1/2013 forward)

Insider Trading and Institutional Ownership History for ABAXIS (NASDAQ:ABAX)

Insider Ownership Percentage: 4.30%
Institutional Ownership Percentage: 97.27%

Institutional Ownership by Quarter for ABAXIS (NASDAQ:ABAX)

Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/26/2017	Achim Henkel	Insider	Sell	650	$48.87	$31,765.50
5/8/2017	Achim Henkel	Director	Sell	8,650	$47.75	$413,037.50
2/2/2017	Richard Bastiani	Director	Sell	4,000	$51.12	$204,480.00
12/6/2016	Clinton Severson	CEO	Sell	15,000	$51.35	$770,250.00
12/2/2016	Kenneth Aron	Insider	Sell	5,000	$51.09	$255,450.00
9/9/2016	Clinton Severson	CEO	Sell	2,000	$48.29	$96,580.00
9/8/2016	Prithipal Singh	Director	Sell	1,000	$49.50	$49,500.00
8/25/2016	Prithipal Singh	Director	Sell	1,500	$50.30	$75,450.00
8/24/2016	Donald Peter Wood	Insider	Sell	8,500	$50.21	$426,785.00
6/9/2016	Richard Bastiani	Director	Sell	5,000	$46.75	$233,750.00
5/17/2016	Achim Henkel	Director	Sell	5,000	$44.43	$222,150.00
5/9/2016	Henk Evenhuis	Director	Sell	3,000	$45.00	$135,000.00
2/9/2016	Vernon E Altman	Director	Buy	303	$39.87	$12,080.61
12/8/2015	Craig Tockman	VP	Sell	560	$54.44	$30,486.40
2/9/2015	Prithipal Singh	Director	Sell	2,500	$60.50	$151,250.00
12/8/2014	Kenneth Aron	CTO	Sell	2,000	$56.68	$113,360.00
11/25/2014	Clinton Severson	CEO	Sell	2,286	$56.00	$128,016.00
11/13/2014	Clinton Severson	CEO	Sell	10,000	$55.00	$550,000.00
11/5/2014	Clinton Severson	CEO	Sell	10,000	$54.00	$540,000.00
11/3/2014	Alberto Santa Ines	CFO	Sell	1,652	$53.09	$87,704.68
11/3/2014	Clinton Severson	CEO	Sell	5,000	$53.00	$265,000.00
10/31/2014	Clinton Severson	CEO	Sell	10,000	$51.50	$515,000.00
8/12/2014	Richard Bastiani	Director	Sell	1,000	$45.40	$45,400.00
7/30/2014	Alberto Santa Ines	CFO	Sell	10,738	$47.81	$513,383.78
7/29/2014	Alberto Santa Ines	CFO	Sell	17,293	$48.01	$830,236.93
6/5/2014	Richard Bastiani	Director	Sell	2,000	$42.10	$84,200.00
6/3/2014	Richard Bastiani	Director	Sell	4,000	$41.88	$167,520.00
5/22/2014	Achim Henkel	Director	Sell	8,500	$41.63	$353,855.00
5/14/2014	Henk Evenhuis	Director	Sell	4,000	$44.06	$176,240.00
5/1/2014	Henk Evenhuis	Director	Sell	4,500	$41.00	$184,500.00
3/4/2014	Vladimir Ostoich	VP	Sell	9,800	$38.53	$377,594.00
2/24/2014	Kenneth Aron	CTO	Sell	1,000	$38.98	$38,980.00
2/13/2014	Donald Peter Wood	COO	Sell	8,864	$38.50	$341,264.00
6/7/2013	Clinton Severson	CEO	Sell	10,000	$44.50	$445,000.00
6/7/2013	Martin Mulroy	Insider	Sell	14,000	$44.80	$627,200.00
5/22/2013	Kenneth Aron	CTO	Sell	4,200	$43.28	$181,776.00
5/7/2013	Achim Henkel	Director	Sell	5,000	$44.07	$220,350.00
3/1/2013	Achim Henkel	Director	Sell	1,000	$42.85	$42,850.00
2/26/2013	Martin Mulroy	Insider	Sell	12,000	$41.84	$502,080.00
2/5/2013	Kenneth Aron	CTO	Sell	40,000	$44.13	$1,765,200.00
2/4/2013	Martin Mulroy	Insider	Sell	12,000	$43.97	$527,640.00
11/23/2012	Richard Bastiani	Director	Sell	5,000	$36.60	$183,000.00

(Data available from 1/1/2013 forward)

Headline Trends for ABAXIS (NASDAQ:ABAX) Latest Headlines for ABAXIS (NASDAQ:ABAX)

Source:

Date	Headline
	ABAXIS, Inc. (ABAX) Given Average Rating of "Hold" by Analysts www.americanbankingnews.com - September 23 at 10:48 PM
	Abaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference finance.yahoo.com - September 19 at 3:18 PM
	Zacks: Analysts Expect ABAXIS, Inc. (ABAX) Will Announce Quarterly Sales of $61.49 Million www.americanbankingnews.com - September 18 at 4:48 AM
	Zacks: Analysts Anticipate ABAXIS, Inc. (ABAX) to Announce $0.29 EPS www.americanbankingnews.com - September 16 at 4:08 PM
	New Strong Sell Stocks for September 11th finance.yahoo.com - September 11 at 3:44 PM
	Abaxis, Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare ... www.prnewswire.com - September 8 at 8:28 PM
	Abaxis, Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare Conference and the CL King 15th Annual Best Ideas Conference 2017 finance.yahoo.com - September 8 at 8:28 PM
	Contrasting Alere (ALR) and ABAXIS (ABAX) www.americanbankingnews.com - September 8 at 6:10 AM
	ETFs with exposure to ABAXIS, Inc. : September 7, 2017 finance.yahoo.com - September 7 at 3:17 PM
	ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q1, 2018 By the Numbers : September 5, 2017 finance.yahoo.com - September 5 at 3:17 PM
	Abaxis, Inc. to Present at the Robert W. Baird & Co. 2017 Global Healthcare Conference finance.yahoo.com - August 31 at 3:17 PM
	Veterinary Diagnostics Market by Product, Technology, Animal Type And End User - Global Forecast to 2022 www.bizjournals.com - August 30 at 8:16 PM
	ABAXIS, Inc. : ABAX-US: Dividend Analysis : September 01st, 2017 (record date) : By the numbers : August 30, 2017 finance.yahoo.com - August 30 at 3:14 PM
	ABAXIS, Inc. (ABAX) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - August 30 at 12:44 AM
	Brokerages Expect ABAXIS, Inc. (ABAX) to Announce $0.29 Earnings Per Share www.americanbankingnews.com - August 29 at 4:08 AM
	Ex-Dividend Reminder: Abaxis, McKesson and Baxter International www.nasdaq.com - August 28 at 3:29 PM
	ABAXIS, Inc. (ABAX) Coverage Initiated by Analysts at Bank of America Corporation www.americanbankingnews.com - August 23 at 9:30 AM
	What Falling Estimates & Price Mean for Abaxis (ABAX) finance.yahoo.com - August 21 at 3:23 PM
	New Strong Sell Stocks for August 21st finance.yahoo.com - August 21 at 3:23 PM
	Veterinary Hematology Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 www.prnewswire.com - August 8 at 8:32 PM
	ABAXIS, Inc. (NASDAQ:ABAX) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - August 5 at 12:38 AM
	ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : August 4, 2017 finance.yahoo.com - August 4 at 2:06 AM
	Abaxis, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference finance.yahoo.com - August 3 at 3:38 PM
	ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : July 31, 2017 finance.yahoo.com - August 2 at 3:15 PM
	ETFs with exposure to ABAXIS, Inc. : August 1, 2017 finance.yahoo.com - August 1 at 8:28 PM
	New Strong Sell Stocks for August 1st finance.yahoo.com - August 1 at 3:27 PM
	Edited Transcript of ABAX earnings conference call or presentation 27-Jul-17 8:15pm GMT finance.yahoo.com - July 28 at 3:29 PM
	Abaxis (ABAX) Misses Earnings & Revenue Estimates in Q1 finance.yahoo.com - July 28 at 3:29 PM
	ABAXIS (ABAX) Q1 2018 Results - Earnings Call Transcript seekingalpha.com - July 28 at 1:31 AM
	ABAXIS, Inc. (ABAX) Issues Earnings Results www.americanbankingnews.com - July 27 at 11:14 PM
	Abaxis Reports Financial Performance for the First Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend finance.yahoo.com - July 27 at 8:30 PM
	Abaxis misses Street 1Q forecasts finance.yahoo.com - July 27 at 8:30 PM
	ABAXIS, Inc. (NASDAQ:ABAX) Plans Quarterly Dividend of $0.14 www.americanbankingnews.com - July 27 at 5:29 PM
	Head to Head Survey: Cogentix Medical (CGNT) vs. ABAXIS (ABAX) www.americanbankingnews.com - July 26 at 8:54 AM
	ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : July 21, 2017 finance.yahoo.com - July 21 at 4:27 PM
	Zacks: Brokerages Expect ABAXIS, Inc. (NASDAQ:ABAX) to Post $0.32 EPS www.americanbankingnews.com - July 21 at 12:28 PM
	Veterinary Chemistry Analyzer Market by Product Application & Animal - Global Forecast to 2022 www.bizjournals.com - July 21 at 1:27 AM
	ABAXIS, Inc. (NASDAQ:ABAX) Set to Announce Quarterly Earnings on Thursday www.americanbankingnews.com - July 20 at 7:51 AM
	Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More finance.yahoo.com - July 19 at 3:20 PM
	Abaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday ... www.prnewswire.com - July 18 at 3:21 PM
	Abaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday, July 27, 2017 finance.yahoo.com - July 18 at 3:21 PM
	ABAXIS, Inc. (ABAX) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - July 17 at 7:30 AM
	ABAXIS, Inc. (NASDAQ:ABAX) Given Hold Rating at Stifel Nicolaus www.americanbankingnews.com - July 15 at 11:18 AM
	Critical Comparison: ABAXIS (ABAX) vs. Accelerate Diagnostics (AXDX) www.americanbankingnews.com - July 14 at 2:32 PM
	ETFs with exposure to ABAXIS, Inc. : July 11, 2017 finance.yahoo.com - July 11 at 4:19 PM
	ABAXIS, Inc. (ABAX) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - July 2 at 12:02 PM
	Abaxis (ABAX) Product Portfolio Strong, Competition Rife finance.yahoo.com - June 30 at 3:24 PM
	ETFs with exposure to ABAXIS, Inc. : June 29, 2017 finance.yahoo.com - June 29 at 3:20 PM
	Zacks: Brokerages Anticipate ABAXIS, Inc. (ABAX) Will Post Quarterly Sales of $60.62 Million www.americanbankingnews.com - June 29 at 11:40 AM
	Analysts Anticipate ABAXIS, Inc. (ABAX) to Post $0.32 Earnings Per Share www.americanbankingnews.com - June 27 at 10:08 AM